We are live on
!
Find out more
IAP
Indie Asset Partners Portfolio holdings
AUM
$87.8M
1-Year Est. Return
27.76%
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+27.76%
3 Year Est. Return
+120.76%
5 Year Est. Return
+150.7%
10 Year Est. Return
–
AUM
$133M
AUM Growth
-$4.68M
(-3.4%)
Cap. Flow
+$665K
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
59.63%
Holding
133
New
7
Increased
44
Reduced
48
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$4.72M |
| 2 |
First Internet Bancorp
INBK
|
+$544K |
| 3 |
Zimmer Biomet
ZBH
|
+$468K |
| 4 |
Global X Copper Miners ETF NEW
COPX
|
+$452K |
| 5 |
Meta Platforms (Facebook)
META
|
+$358K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$1.93M |
| 2 |
Marvell Technology
MRVL
|
+$516K |
| 3 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$420K |
| 4 |
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
|
+$397K |
| 5 |
Commault Systems
CVLT
|
+$348K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.12% |
| 2 | Technology | 10.06% |
| 3 | Consumer Discretionary | 4.09% |
| 4 | Industrials | 3.44% |
| 5 | Financials | 3.27% |
Similar funds
DG
XXIP
CVM
BCP
PM
PBCM
S2L
IC
Indie Asset Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Indie Asset Partners held 133 positions worth $133M, down 3.4% from $138M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Indie Asset Partners's Q1 2022 filing shows 7 new, 44 increased, 48 reduced and 9 closed positions. Its largest new stake was First Internet Bancorp: 11,250 shares worth $484K. The largest sale was Royalty Pharma, an estimated $1.93M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.
- Indie Asset Partners's largest Q1 2022 buy was First Internet Bancorp: 11,250 shares worth $484K.
- Indie Asset Partners added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q1 2022, an estimated $4.72M increase.
- Indie Asset Partners's biggest Q1 2022 reduction was Royalty Pharma, cutting an estimated $1.93M.
- Indie Asset Partners fully exited Marvell Technology in Q1 2022, selling an estimated $516K.
- Indie Asset Partners's ten largest holdings make up 60% of its $133M portfolio in Q1 2022.
- Indie Asset Partners opened 7 new positions and closed 9 in Q1 2022.
- Indie Asset Partners's portfolio value fell 3.4% quarter-over-quarter to $133M.
Based on Indie Asset Partners's 13F filing for Q1 2022, filed 10 May 2022.